Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC43A1 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC43A1 mRNA | CTD | PMID:36331819 | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC43A1 mRNA | CTD | PMID:17942748 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Metribolone results in increased expression of SLC43A1 mRNA | CTD | PMID:17010196 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of SLC43A1 mRNA | CTD | PMID:29581250 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC43A1 mRNA more ... | CTD | PMID:15034205 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC43A1 mRNA | CTD | PMID:15034205 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC43A1 mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC43A1 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC43A1 mRNA | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of SLC43A1 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SLC43A1 mRNA | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SLC43A1 mRNA | CTD | PMID:28973697 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SLC43A1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | affects expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SLC43A1 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SLC43A1 mRNA | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC43A1 mRNA | CTD | PMID:33167477 | arsane | affects methylation | ISO | SLC43A1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC43A1 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | SLC43A1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC43A1 gene | CTD | PMID:25304211 | arsenous acid | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of SLC43A1 mRNA | CTD | PMID:24356939 | belinostat | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | belinostat results in increased expression of SLC43A1 mRNA | CTD | PMID:26272509 | benzo[a]pyrene | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of SLC43A1 mRNA] | CTD | PMID:15034205 | benzo[a]pyrene | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene metabolite results in decreased expression of SLC43A1 mRNA and Benzo(a)pyrene results in decreased expression of SLC43A1 mRNA | CTD | PMID:24356939 and PMID:32234424 | benzo[a]pyrene | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC43A1 mRNA | CTD | PMID:15034205 | benzo[b]fluoranthene | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of SLC43A1 mRNA | CTD | PMID:26377693 | Benzo[k]fluoranthene | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of SLC43A1 mRNA | CTD | PMID:26377693 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC43A1 mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SLC43A1 mRNA] | CTD | PMID:19850644 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC43A1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | bisphenol A analog results in increased expression of SLC43A1 mRNA and bisphenol A results in increased expression of SLC43A1 mRNA | CTD | PMID:27685785 and PMID:32387340 | bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of SLC43A1 mRNA | CTD | PMID:32479839 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of SLC43A1 mRNA | CTD | PMID:19167457 | caffeine | decreases phosphorylation | ISO | SLC43A1 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of SLC43A1 protein | CTD | PMID:35688186 | calcitriol | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SLC43A1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC43A1 mRNA | CTD | PMID:21592394 | carbon nanotube | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of SLC43A1 mRNA | CTD | PMID:25620056 | cisplatin | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SLC43A1 mRNA | CTD | PMID:27392435 | cyclophosphamide | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Cyclophosphamide metabolite results in decreased expression of SLC43A1 mRNA | CTD | PMID:24356939 | cyclosporin A | affects expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Cyclosporine affects the expression of SLC43A1 mRNA | CTD | PMID:25562108 | cyclosporin A | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC43A1 mRNA | CTD | PMID:27989131 | dexamethasone | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of SLC43A1 mRNA | CTD | PMID:22733784 | diarsenic trioxide | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of SLC43A1 mRNA | CTD | PMID:24356939 | dibenz[a,h]anthracene | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dibutyl phthalate | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of SLC43A1 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SLC43A1 mRNA | CTD | PMID:21266533 | diclofenac | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Diclofenac results in increased expression of SLC43A1 mRNA | CTD | PMID:26934552 | dorsomorphin | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC43A1 mRNA | CTD | PMID:29803840 | doxorubicin | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of SLC43A1 mRNA | CTD | PMID:36227756 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SLC43A1 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | entinostat results in increased expression of SLC43A1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC43A1 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SLC43A1 mRNA | CTD | PMID:35436446 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of SLC43A1 mRNA | CTD | PMID:24136188 | folic acid | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Folic Acid results in increased expression of SLC43A1 mRNA | CTD | PMID:25629700 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of SLC43A1 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SLC43A1 mRNA | CTD | PMID:33387578 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of SLC43A1 mRNA | CTD | PMID:24136188 | isoflavones | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Isoflavones results in decreased expression of SLC43A1 mRNA | CTD | PMID:17374662 | methyl methanesulfonate | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SLC43A1 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of SLC43A1 mRNA | CTD | PMID:28001369 | mifepristone | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Mifepristone results in decreased expression of SLC43A1 mRNA | CTD | PMID:17584828 | motexafin gadolinium | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC43A1 mRNA | CTD | PMID:16357179 | motexafin gadolinium | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of SLC43A1 mRNA | CTD | PMID:16357179 | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of SLC43A1 mRNA | CTD | PMID:24136188 | niclosamide | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of SLC43A1 mRNA | CTD | PMID:36318118 | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of SLC43A1 mRNA | CTD | PMID:33484710 | ochratoxin A | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | ochratoxin A metabolite results in decreased expression of SLC43A1 mRNA | CTD | PMID:24356939 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC43A1 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of SLC43A1 mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of SLC43A1 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC43A1 mRNA | CTD | PMID:34911549 | panobinostat | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SLC43A1 mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC43A1 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC43A1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC43A1 mRNA | CTD | PMID:22230336 | perfluorononanoic acid | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SLC43A1 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc43a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC43A1 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SLC43A1 mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of SLC43A1 mRNA | CTD | PMID:20813756 and PMID:23811191 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SLC43A1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SLC43A1 mRNA | CTD | PMID:34032870 | sunitinib | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SLC43A1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC43A1 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of SLC43A1 mRNA | CTD | PMID:21592394 | tetrachloromethane | affects expression | ISO | Slc43a1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SLC43A1 mRNA | CTD | PMID:17484886 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC43A1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SLC43A1 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC43A1 mRNA | CTD | PMID:23411599 and PMID:34492290 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of SLC43A1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC43A1 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of SLC43A1 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC43A1 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SLC43A1 mRNA | CTD | PMID:24935251 | trimellitic anhydride | decreases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of SLC43A1 mRNA | CTD | PMID:19042947 | triptonide | increases expression | ISO | Slc43a1 (Mus musculus) | 6480464 | triptonide results in increased expression of SLC43A1 mRNA | CTD | PMID:33045310 | tunicamycin | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of SLC43A1 mRNA | CTD | PMID:22378314 and PMID:29453283 | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of SLC43A1 mRNA | CTD | PMID:24136188 | valproic acid | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC43A1 mRNA | CTD | PMID:24383497 more ... | valproic acid | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC43A1 mRNA | CTD | PMID:27188386 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of SLC43A1 mRNA | CTD | PMID:23034163 | zinc acetate | increases expression | ISO | SLC43A1 (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of SLC43A1 mRNA | CTD | PMID:16357179 | zinc acetate | multiple interactions | ISO | SLC43A1 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of SLC43A1 mRNA | CTD | PMID:16357179 | |